{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:15:42Z","timestamp":1793369742794,"version":"4.5.0"},"reference-count":126,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Psoriasis is a chronic inflammatory disease of the skin and joints associated with several comorbidities such as arthritis, diabetes mellitus and metabolic syndrome, including obesity, hypertension and dyslipidaemia, Crohn\u2019s disease, uveitis and psychiatric and psychological diseases. Psoriasis has been described as an independent risk factor for cardiovascular diseases and thus patients with psoriasis should be monitored for the development of cardiovascular disease or metabolic syndrome. However, there is mounting evidence that psoriasis also affects the development of osteoporosis, an important metabolic disease with enormous clinical and socioeconomic impact. At present, there are still controversial opinions about the role of psoriasis in osteoporosis. A more in depth analysis of this phenomenon is of great importance for affected patients since, until now, bone metabolism is not routinely examined in psoriatic patients, which might have important long-term consequences for patients and the health system. In the present review, we summarize current knowledge on the impact of psoriatic inflammation on bone metabolism and osteoporosis.<\/jats:p>","DOI":"10.3389\/fimmu.2022.925503","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T04:24:30Z","timestamp":1655958270000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Impact of Chronic Inflammation in Psoriasis on Bone Metabolism"],"prefix":"10.3389","volume":"13","author":[{"given":"Anja","family":"Saalbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1201\/9781420028836.ch14","article-title":"Regulation of Bone Metabolism","volume":"5","author":"Shahi","year":"2017","journal-title":"Rep Biochem Mol Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41574-019-0264-9","article-title":"Function of Soluble RANKL Deciphered","volume":"15","author":"Greenhill","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00283-7","article-title":"Revisiting Osteoporosis Guidelines","volume":"9","author":"Reid","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-011110-130203","article-title":"Disorders of Bone Remodeling","volume":"6","author":"Feng","year":"2011","journal-title":"AnnuRevPathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/1759720X11430858","article-title":"Aging and Bone Loss: New Insights for the Clinician","volume":"4","author":"Demontiero","year":"2012","journal-title":"TherAdvMusculoskeletDis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-08-0568","article-title":"Bone Loss in Inflammatory Disorders","volume":"201","author":"Hardy","year":"2009","journal-title":"J Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.104786","article-title":"Interleukin-1 is Essential for Systemic Inflammatory Bone Loss","volume":"69","author":"Polzer","year":"2010","journal-title":"AnnRheumDis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3669","article-title":"Inflammatory Bone Loss: Pathogenesis and Therapeutic Intervention","volume":"11","author":"Redlich","year":"2012","journal-title":"Nat Rev Drug Discovery"},{"key":"B9","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s00223-017-0335-7","article-title":"Glucocorticoids, Inflammation and Bone","volume":"102","author":"Guler-Yuksel","year":"2018","journal-title":"Calcif Tissue Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101124","article-title":"Cardiovascular Comorbidities in Psoriasis and Psoriatic Arthritis: Pathogenesis, Consequences for Patient Management, and Future Research Agenda: A Report From the GRAPPA 2009 Annual Meeting","volume":"38","author":"Boehncke","year":"2011","journal-title":"J Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/art.40499","article-title":"Correlation of High-Density Lipoprotein-Associated Paraoxonase 1 Activity With Systemic Inflammation, Disease Activity, and Cardiovascular Risk Factors in Psoriatic Disease","volume":"70","author":"Husni","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.08.042","article-title":"Research Gaps in Psoriasis: Opportunities for Future Studies","volume":"70","author":"Ryan","year":"2014","journal-title":"JAmAcadDermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","article-title":"The Immunogenetics of Psoriasis: A Comprehensive Review","volume":"64","author":"Harden","year":"2015","journal-title":"J Autoimmun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddh094","article-title":"The Genetics of Psoriasis, Psoriatic Arthritis and Atopic Dermatitis","author":"Bowcock","year":"2004","journal-title":"HumMolGenet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20151093","article-title":"Melanocyte Antigen Triggers Autoimmunity in Human Psoriasis","volume":"212","author":"Arakawa","year":"2015","journal-title":"JExpMed"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/7.10.1537","article-title":"The Genetics of Psoriasis: A Complex Disorder of the Skin and Immune System","volume":"7","author":"Bhalerao","year":"1998","journal-title":"HumMolGenet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2010.06.006","article-title":"Psoriasis Genetics: Breaking the Barrier","volume":"26","author":"Roberson","year":"2010","journal-title":"Trends Genet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddn091","article-title":"Identification of ZNF313\/RNF114 as a Novel Psoriasis Susceptibility Gene","volume":"17","author":"Capon","year":"2008","journal-title":"HumMolGenet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3528","article-title":"Analysis of Five Chronic Inflammatory Diseases Identifies 27 New Associations and Highlights Disease-Specific Patterns at Shared Loci","volume":"48","author":"Ellinghaus","year":"2016","journal-title":"NatGenet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.311","article-title":"Genome-Wide Scan Reveals Association of Psoriasis With IL-23 and NF-kappaB Pathways","volume":"41","author":"Nair","year":"2009","journal-title":"NatGenet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2015.10.019","article-title":"Genome-Wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture","volume":"97","author":"Stuart","year":"2015","journal-title":"AmJHumGenet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/ng.310","article-title":"Psoriasis Genome-Wide Association Study Identifies Susceptibility Variants Within LCE Gene Cluster at 1q21","volume":"41","author":"Zhang","year":"2009","journal-title":"NatGenet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01682","article-title":"The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond","volume":"9","author":"Brembilla","year":"2018","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800013","article-title":"Discovery of the IL-23\/IL-17 Signaling Pathway and the Treatment of Psoriasis","volume":"201","author":"Hawkes","year":"2018","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08135.x","article-title":"Psoriasis: Evolution of Pathogenic Concepts and New Therapies Through Phases of Translational Research","volume":"157","author":"Guttman-Yassky","year":"2007","journal-title":"Br J Dermatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the Pathogenesis of Psoriasis: From Keratinocyte Perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1600266","article-title":"The Human Intestinal Microbiome in Health and Disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.764384","article-title":"Interplay Between Skin Microbiota Dysbiosis and the Host Immune System in Psoriasis: Potential Pathogenesis","volume":"12","author":"Liang","year":"2021","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17989","article-title":"Combined Culture and Metagenomic Analyses Reveal Significant Shifts in the Composition of the Cutaneous Microbiome in Psoriasis","volume":"181","author":"Langan","year":"2019","journal-title":"Br J Dermatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.21245","article-title":"Patients With Psoriasis Have a Dysbiotic Taxonomic and Functional Gut Microbiota","author":"Todberg","year":"2022","journal-title":"Br J Dermatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2019.100009","article-title":"The Skin Microbiome in Psoriatic Disease: A Systematic Review and Critical Appraisal","volume":"2","author":"Yerushalmi","year":"2019","journal-title":"J Transl Autoimmun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01256-2","article-title":"Development of a Human Skin Commensal Microbe for Bacteriotherapy of Atopic Dermatitis and Use in a Phase 1 Randomized Clinical Trial","volume":"27","author":"Nakatsuji","year":"2021","journal-title":"Nat Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1744666X.2022.2039121","article-title":"Comparing Available JAK Inhibitors for Treating Patients With Psoriasis","volume":"10","author":"Funk","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.det.2014.09.002","article-title":"The Immunopathogenesis of Psoriasis","volume":"33","author":"Kim","year":"2015","journal-title":"Dermatol Clin"},{"key":"B38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12016-007-0039-2","article-title":"Immunopathogenesis of Psoriasis","volume":"33","author":"Nickoloff","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15159","article-title":"Psoriasis, Metabolic Syndrome and Cardiovascular Risk Factors","volume":"33","author":"Fernandez-Armenteros","year":"2019","journal-title":"A Population-based Study J Eur Acad Dermatol Venereol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-016-3805-3","article-title":"[Comorbidity in Psoriasis]","volume":"67","author":"Gerdes","year":"2016","journal-title":"Hautarzt"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22260","article-title":"Serum Levels of Adipokines and Cytokines in Psoriasis Patients: A Systematic Review and Meta-Analysis","volume":"9","author":"Bai","year":"2018","journal-title":"Oncotarget"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646774","article-title":"Psoriatic Cutaneous Inflammation Promotes Human Monocyte Differentiation Into Active Osteoclasts, Facilitating Bone Damage","volume":"47","author":"Raimondo","year":"2017","journal-title":"EurJImmunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.599947","article-title":"Interleukin 17 Promotes Expression of Alarmins S100A8 and S100A9 During the Inflammatory Response of Keratinocytes","volume":"11","author":"Christmann","year":"2021","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07198.x","article-title":"Elevated Serum Levels of Calcium-Binding S100 Proteins A8 and A9 Reflect Disease Activity and Abnormal Differentiation of Keratinocytes in Psoriasis","volume":"155","author":"Benoit","year":"2006","journal-title":"Br J Dermatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-002-0812-5","article-title":"Evidence for Differential S100 Gene Over-Expression in Psoriatic Patients From Genetically Heterogeneous Pedigrees","volume":"111","author":"Semprini","year":"2002","journal-title":"Hum Genet"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.11.011","article-title":"S100A8-S100A9 Protein Complex Mediates Psoriasis by Regulating the Expression of Complement Factor C3","volume":"39","author":"Schonthaler","year":"2013","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186791","article-title":"Psoriasis and Antimicrobial Peptides","volume":"21","author":"Takahashi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13269","article-title":"Among the S100 Proteins, S100A12 Is the Most Significant Marker for Psoriasis Disease Activity","volume":"30","author":"Wilsmann-Theis","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez218","article-title":"Fc-Gamma Receptors and S100A8\/A9 Cause Bone Erosion During Rheumatoid Arthritis. Do They Act as Partners in Crime","volume":"58","author":"Di Ceglie","year":"2019","journal-title":"Rheumatology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.5483\/BMBRep.2017.50.2.170","article-title":"Extracellular S100A4 Negatively Regulates Osteoblast Function by Activating the NF-\u03bab Pathway","volume":"50","author":"Kim","year":"2017","journal-title":"BMB Rep"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/art.30290","article-title":"S100A8 Enhances Osteoclastic Bone Resorption In Vitro Through Activation of Toll-Like Receptor 4: Implications for Bone Destruction in Murine Antigen-Induced Arthritis","volume":"63","author":"Grevers","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204140","article-title":"S100A12 Facilitates Osteoclast Differentiation From Human Monocytes","volume":"13","author":"Nishida","year":"2018","journal-title":"PloS One"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/7149408","article-title":"S100A9 Increases IL-6 and RANKL Expressions Through MAPKs and STAT3 Signaling Pathways in Osteocyte-Like Cells","volume":"2020","author":"Takagi","year":"2020","journal-title":"BioMed Res Int"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3VMA1014-482R","article-title":"Neutrophil-Derived MRP-14 is Up-Regulated in Infectious Osteomyelitis and Stimulates Osteoclast Generation","volume":"98","author":"Dapunt","year":"2015","journal-title":"J Leukoc Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/der2.60","article-title":"Evaluation of Tissue and Serum Lipocalin 2 in Psoriasis Vulgaris and its Implications on Subclinical Atherosclerosis","volume":"2","author":"Hassab-El-Naby","year":"2021","journal-title":"Dermatol Rev"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8171373","article-title":"Relationship Between the Degrees of Itch and Serum Lipocalin-2 Levels in Patients With Psoriasis","volume":"2019","author":"Aizawa","year":"2019","journal-title":"J Immunol Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13227","article-title":"Lipocalin-2 Exacerbates Psoriasiform Skin Inflammation by Augmenting T-Helper 17 Response","volume":"43","author":"Hau","year":"2016","journal-title":"J Dermatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2341","article-title":"Lipocalin 2: A New Mechanoresponding Gene Regulating Bone Homeostasis","volume":"30","author":"Rucci","year":"2015","journal-title":"J Bone Miner Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2021.101059","article-title":"Lipocalin 2 Serum Levels Correlate With Age and Bone Turnover Biomarkers in Healthy Subjects But Not in Postmenopausal Osteoporotic Women","volume":"14","author":"Maurizi","year":"2021","journal-title":"Bone Rep"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2546","article-title":"Circulating Lipocalin 2 Levels Predict Fracture-Related Hospitalizations in Elderly Women: A Prospective Cohort Study","volume":"30","author":"Lim","year":"2015","journal-title":"J Bone Miner Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02746","article-title":"Psoriasis: Classical vs Paradoxical Yin-Yang TNF Type I Interferon","volume":"9","author":"Mylonas","year":"2018","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02925","article-title":"TNF-\u03b1 Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation","volume":"10","author":"Marahleh","year":"2019","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2018.8698","article-title":"TNF\u2212\u03b1 and RANKL Promote Osteoclastogenesis by Upregulating RANK via the NF\u2212\u03bab Pathway","volume":"17","author":"Luo","year":"2018","journal-title":"Mol Med Rep"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2016.1174328","article-title":"Serum Interleukin-6 Levels in Response to Biologic Treatment in Patients With Psoriasis","volume":"27","author":"Muramatsu","year":"2017","journal-title":"Mod Rheumatol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abe3037","article-title":"Oncostatin M can Sensitize Sensory Neurons in Inflammatory Pruritus","volume":"13","author":"Tseng","year":"2021","journal-title":"Sci Transl Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12694","article-title":"The Oncostatin M-Stromal Cell Axis in Health and Disease","volume":"88","author":"West","year":"2018","journal-title":"Scand J Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in Inflammation, Autoimmunity and Cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.11.022","article-title":"IL-6 Differs From TNF-\u03b1: Unpredicted Clinical Effects Caused by IL-6 Blockade in Psoriasis","volume":"137","author":"Blauvelt","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89384","article-title":"Interleukin 6 Regulates Psoriasiform Inflammation\u2013Associated Thrombosis","volume":"1","author":"Wang","year":"2016","journal-title":"JCI Insight"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0419-z","article-title":"Translating IL-6 Biology Into Effective Treatments","volume":"16","author":"Choy","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00788","article-title":"Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma","volume":"9","author":"Harmer","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B72","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1369\/0022155415611931","article-title":"Long-Term Administration of High-Fat Diet Corrects Abnormal Bone Remodeling in the Tibiae of Interleukin-6-Deficient Mice","volume":"64","author":"Feng","year":"2016","journal-title":"J Histochem Cytochem"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.5.2032","article-title":"Serum Interleukin 6 Is a Major Predictor of Bone Loss in Women Specific to the First Decade Past Menopause","volume":"86","author":"Scheidt-Nave","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201546216","article-title":"Oncostatin M Overexpression Induces Skin Inflammation But is Not Required in the Mouse Model of Imiquimod-Induced Psoriasis-Like Inflammation","volume":"46","author":"Pohin","year":"2016","journal-title":"Eur J Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/bonekey.2014.22","article-title":"Osteoimmunology: Oncostatin M as a Pleiotropic Regulator of Bone Formation and Resorption in Health and Disease","volume":"3","author":"Sims","year":"2014","journal-title":"Bonekey Rep"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063287","article-title":"Stimulation of Osteoclast Formation by Oncostatin M and the Role of WNT16 as a Negative Feedback Regulator","volume":"23","author":"de Souza","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/7420823","article-title":"IL-17A in the Psoriatic Patients\u2019 Serum and Plaque Scales as Potential Marker of the Diseases Severity and Obesity","volume":"2020","author":"Michalak-Stoma","year":"2020","journal-title":"Mediators Inflammation"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00954","article-title":"Human Leukocyte Antigen-Class I Alleles and the Autoreactive T Cell Response in Psoriasis Pathogenesis","volume":"9","author":"Prinz","year":"2018","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01323","article-title":"The Interleukin-23\/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis","volume":"9","author":"Schon","year":"2018","journal-title":"Front Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, A T(H)17 Cytokine, Mediates IL-23-Induced Dermal Inflammation and Acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001001","article-title":"IL-23-Mediated Psoriasis-Like Epidermal Hyperplasia is Dependent on IL-17a","volume":"186","author":"Rizzo","year":"2011","journal-title":"JImmunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03096","article-title":"IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications","volume":"10","author":"von Stebut","year":"2020","journal-title":"Front Immunol"},{"key":"B83","first-page":"17","article-title":"Role of IL-17A Signalling in Psoriasis and Associated Bone Loss","volume":"34","author":"Uluckan","year":"2016","journal-title":"ClinExpRheumatol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.730164","article-title":"Reduced Serum Levels of Bone Formation Marker P1NP in Psoriasis","volume":"8","author":"Mentzel","year":"2021","journal-title":"Front Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"330ra37","DOI":"10.1126\/scitranslmed.aad8996","article-title":"Chronic Skin Inflammation Leads to Bone Loss by IL-17-Mediated Inhibition of Wnt Signaling in Osteoblasts","volume":"8","author":"Uluckan","year":"2016","journal-title":"SciTranslMed"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2014.975683","article-title":"Changes of Serum Cytokines-Related Th1\/Th2\/Th17 Concentration in Patients With Postmenopausal Osteoporosis","volume":"31","author":"Zhang","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.24165","article-title":"IL-17 Mediates Estrogen-Deficient Osteoporosis in an Act1-Dependent Manner","volume":"113","author":"Deselm","year":"2012","journal-title":"J Cell Biochem"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8659302","article-title":"Implication of IL-17 in Bone Loss and Structural Damage in Inflammatory Rheumatic Diseases","volume":"2019","author":"Le Goff","year":"2019","journal-title":"Mediators Inflammation"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204782","article-title":"IL-17A Gene Transfer Induces Bone Loss and Epidermal Hyperplasia Associated With Psoriatic Arthritis","volume":"74","author":"Adamopoulos","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.22326","article-title":"IL-17 Induces Osteoclastogenesis From Human Monocytes Alone in the Absence of Osteoblasts, Which is Potently Inhibited by Anti-TNF-\u03b1 Antibody: A Novel Mechanism of Osteoclastogenesis by IL-17","volume":"108","author":"Yago","year":"2009","journal-title":"J Cell Biochem"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/art.37762","article-title":"Interleukin-17A Stimulates Granulocyte-Macrophage Colony-Stimulating Factor Release by Murine Osteoblasts in the Presence of 1,25-Dihydroxyvitamin D 3 and Inhibits Murine Osteoclast Development","volume":"65","author":"Balani","year":"2013","journal-title":"Vitro Arthritis Rheum"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25220","article-title":"Different Blood-Borne Human Osteoclast Precursors Respond in Distinct Ways to IL-17a","volume":"231","author":"Sprangers","year":"2016","journal-title":"J Cell Physiol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jare.2014.01.011","article-title":"Vitamin D and the Skin: Focus on a Complex Relationship: A Review","volume":"6","author":"Mostafa","year":"2013","journal-title":"J Adv Res"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.604055","article-title":"IL-33\/Vitamin D Crosstalk in Psoriasis-Associated Osteoporosis","volume":"11","author":"De Martinis","year":"2021","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13381","article-title":"Association Between Circulating 25-Hydroxyvitamin D Levels and Psoriasis, and Correlation With Disease Severity: A Meta-Analysis","volume":"43","author":"Lee","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2016.2718","article-title":"Low Vitamin D-Modulated Calcium-Regulating Proteins in Psoriasis Vulgaris Plaques: S100A7 Overexpression Depends on Joint Involvement","volume":"38","author":"Cubillos","year":"2016","journal-title":"Int J Mol Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12020-018-1588-2","article-title":"Glucocorticoid-Induced Osteoporosis: An Update","volume":"61","author":"Compston","year":"2018","journal-title":"Endocrine"},{"key":"B98","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jamadermatol.2020.4968","article-title":"Association of Potent and Very Potent Topical Corticosteroids and the Risk of Osteoporosis and Major Osteoporotic Fractures","volume":"157","author":"Egeberg","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4491-z","article-title":"Risk of Fragility Fracture Among Patients With Late-Onset Psoriasis: A UK Population-Based Study","volume":"29","author":"Paskins","year":"2018","journal-title":"Osteoporos Int"},{"key":"B100","article-title":"Methotrexate (MTX) Inhibits Osteoblastic Differentiation In Vitro: Possible Mechanism of MTX Osteopathy","volume":"28","author":"Uehara","year":"2001","journal-title":"J Rheumatol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2019.02.005","article-title":"Osteoporosis and Psoriasis","volume":"110","author":"Mu\u00f1oz-Torres","year":"2019","journal-title":"Actas Dermosifiliogr"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-012-1940-y","article-title":"The Effects of Smoking on Bone Metabolism","volume":"23","author":"Yoon","year":"2012","journal-title":"Osteoporos Int"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12670","article-title":"Psoriasis and Smoking: A Systematic Review and Meta-Analysis","volume":"170","author":"Armstrong","year":"2014","journal-title":"Br J Dermatol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.amjmed.2007.12.007","article-title":"High Incidence of Smoking Habit in Psoriatic Patients","volume":"121","author":"Favato","year":"2008","journal-title":"Am J Med"},{"key":"B105","article-title":"Alcohol and Other Factors Affecting Osteoporosis Risk in Women","volume":"26","author":"Sampson","year":"2002","journal-title":"Alcohol Res Heal"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1097\/01.alc.0000192039.21305.55","article-title":"Alcohol-Induced Bone Loss and Deficient Bone Repair","volume":"29","author":"Chakkalakal","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12164","article-title":"Alcohol Consumption and Psoriasis: A Systematic Literature Review","volume":"27","author":"Brenaut","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18979","article-title":"What are the Barriers to Physical Activity in Patients With Chronic Plaque Psoriasis?*","volume":"183","author":"Auker","year":"2020","journal-title":"Br J Dermatol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s13555-021-00662-1","article-title":"Assessment of Life Quality, Stress and Physical Activity Among Patients With Psoriasis","volume":"12","author":"Nowowiejska","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/5747852","article-title":"Association of Trabecular Bone Score With Inflammation and Adiposity in Patients With Psoriasis: Effect of Adalimumab Therapy","volume":"2016","author":"Hern\u00e1ndez","year":"2016","journal-title":"J Osteoporos"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0403","article-title":"Risk Factors for Osteoporosis and Bone Status in Postmenopausal Women With Psoriasis Treated With UVB Therapy","volume":"88","author":"Osmancevic","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2521","article-title":"Quantitative and Qualitative Changes of Bone in Psoriasis and Psoriatic Arthritis Patients","volume":"30","author":"Kocijan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2001.00855.x","article-title":"Bone Mineral Density of Patients With Chronic Plaque Psoriasis","volume":"26","author":"Millard","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15123","article-title":"Psoriasis, Fracture Risk and Bone Mineral Density: The HUNT Study, Norway","volume":"176","author":"Modalsli","year":"2017","journal-title":"Br J Dermatol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217892","article-title":"Systemic Evaluation of the Relationship Between Psoriasis, Psoriatic Arthritis and Osteoporosis: Observational and Mendelian Randomisation Study","volume":"79","author":"Xia","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-012-2185-5","article-title":"Association Between Osteoporosis and Psoriasis: Results From the Longitudinal Health Insurance Database in Taiwan","volume":"24","author":"Keller","year":"2013","journal-title":"Osteoporos Int"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jaad.2016.11.046","article-title":"Association of Psoriasis and Psoriatic Arthritis With Osteoporosis and Pathological Fractures","volume":"76","author":"Kathuria","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40364-017-0097-4","article-title":"Bone Biomarker for the Clinical Assessment of Osteoporosis: Recent Developments and Future Perspectives","volume":"5","author":"Kuo","year":"2017","journal-title":"BiomarkRes"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210441","article-title":"The Risk of Fracture Among Patients With Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis","volume":"76","author":"Harter","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_831_17","article-title":"Linking of Psoriasis With Osteopenia and Osteoporosis: A Cross-Sectional Study","volume":"85","author":"Martinez-Lopez","year":"2019","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210441","article-title":"The Risk of Fracture Among Patients With Psoriatic Arthritis and Psoriasis: A Population-Based Study","volume":"76","author":"Ogdie","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-020-05724-2","article-title":"Psoriasis is Associated With an Increased Risk of Osteoporosis: Follow-Up and Nested Case\u2013Control Studies Using a National Sample Cohort","volume":"32","author":"Lee","year":"2021","journal-title":"Osteoporos Int"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12546","article-title":"Psoriasis and Bone Mineral Density: Implications for Long-Term Patients","volume":"41","author":"D\u2019Epiro","year":"2014","journal-title":"J Dermatol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.3390\/jcm9113712","article-title":"Bone Mineral Density, Osteoporosis, and Fracture Risk in Adult Patients With Psoriasis or Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Observational Studies","volume":"9","author":"Chen","year":"2020","journal-title":"J Clin Med"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14630","article-title":"The Association Between Psoriasis and Psoriatic Arthritis With the Risk of Osteoporosis, Osteopenia and Bone Fractures: A Systematic Review and Meta-Analysis","volume":"75","author":"Sepehri","year":"2021","journal-title":"Int J Clin Pract"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3390\/nu13093015","article-title":"Biologic Treatment in Combination With Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical Trial","volume":"13","author":"Pinter","year":"2021","journal-title":"Nutrients"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.925503\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T04:24:34Z","timestamp":1655958274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.925503\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":126,"alternative-id":["10.3389\/fimmu.2022.925503"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.925503","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"article-number":"925503"}}